Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CD7-C52H9 | Cynomolgus | Cynomolgus CD117 / c-kit Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H82E6 | Human | Biotinylated Human CD117 / c-kit Protein, His,Avitag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-R5259 | Rhesus macaque | Rhesus macaque CD117 / c-kit Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-M5259 | Mouse | Mouse CD117 / c-kit Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H5255 | Human | Human CD117 / c-kit Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H52H4 | Human | Human CD117 / c-kit Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
Immobilized ActiveMax® Human SCF, His Tag (Cat. No. SCF-H4219) at 2 μg/mL (100 μL/well) can bind Biotinylated Human CD117, His,Avitag (Cat. No. CD7-H82E6) with a linear range of 0.02-0.625 μg/mL (QC tested).
The purity of Cynomolgus CD117, His Tag (Cat. No. CD7-C52H9) is more than 90% and the molecular weight of this protein is around 68-88 kDa verified by SEC-MALS.
Immobilized Cynomolgus CD117, His Tag (Cat. No. CD7-C52H9) at 2 μg/mL (100 μL/well) can bind Biotinylated Human SCF, Avitag,His Tag (Cat. No. SCF-H82E1) with a linear range of 0.2-5 ng/mL (QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Midostaurin | PKC-412; PKC-412A; CGP-41231; CGP-41251 | Approved | Novartis Pharma Ag | Rydapt | EU | Leukemia, Myeloid, Acute; Mastocytosis | Novartis Europharm Ltd | 2017-04-28 | Leukemia; Hematologic Neoplasms; Mastocytosis, Systemic; Leukemia, Mast-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hepatic Insufficiency; Leukemia, Myeloid, Acute; Mastocytosis | Details |
Ancestim | AMJ-9302 | Approved | Amgen Inc | Stemgen | Hematopoietic stem cell transplantation (HSCT) | Details | ||||
Imatinib mesylate | CGP-57148B; CGP-57148; STI-571; QTI-571; CTI-571; AER-901; VR325 | Approved | Novartis Pharma Ag | glivic, 格列卫, Gleevec, Ruvise, Glivec, Gleevec/Glivec | United States | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Novartis Pharma Ag | 2001-05-10 | Chronic eosinophilic leukemia (CEL); Prostatic Diseases; Myelodysplastic-Myeloproliferative Diseases; Acute Lung Injury; Leukemia, Myeloid, Acute; Urogenital Neoplasms; Pulmonary Edema; Philadelphia Chromosome; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Chronic-Phase; Neurofibrosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Pulmonary Arterial Hypertension; Chordoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Respiratory Distress Syndrome, Adult; Leukemia, Myelomonocytic, Chronic; Glioblastoma; Dermatofibrosarcoma; Mastocytosis, Systemic; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Rhinitis, Allergic, Seasonal; Genital Neoplasms, Male; Abdominal Neoplasms; Leukemia; Genital Diseases, Male; Hypereosinophilic Syndrome | Details |
Pexidartinib | PLX-3397 | Approved | Daiichi Sankyo Co Ltd | Turalio | United States | Giant Cell Tumor of Tendon Sheath | Daiichi Sankyo Inc | 2019-08-02 | Giant Cell Tumor of Tendon Sheath; Solid tumours; Synovitis, Pigmented Villonodular; Hodgkin Disease; Arthritis, Rheumatoid; Glioblastoma; Giant Cell Tumors; Prostatic Neoplasms; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute | Details |
Cabozantinib S-malate | XL-184; BMS-907351 | Approved | Exelixis Inc | Cometriq, Cabometyx | Japan | Carcinoma, Renal Cell | Takeda | 2012-11-29 | Solid tumours; Carcinoma, Renal Cell; Stomach Neoplasms; Pain; Esophageal Neoplasms; Glioblastoma; Kidney Diseases; Prostatic Neoplasms; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Thyroid Neoplasms; Carcinoma, Neuroendocrine; Lymphoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung | Details |
Avapritinib | BLU-285; CS-3007 | Approved | Blueprint Medicines Corp | Ayvakit, Ayvakyt, 泰吉华 | Hong Kong | Gastrointestinal Stromal Tumors | Cstone Pharmaceuticals | 2020-01-09 | Solid tumours; Hematologic Neoplasms; Mastocytosis, Systemic; Leukemia, Mast-Cell; Central Nervous System Neoplasms; Gastrointestinal Stromal Tumors | Details |
Pazopanib Hydrochloride | GW-786034; SB-786034; GSK-786034; GW-786034B | Approved | Glaxosmithkline Plc, Novartis Pharma Ag | 维全特, Armala, Patorma, Votrient | Mainland China | Carcinoma, Renal Cell | Novartis Pharma Schweiz Ag | 2009-10-19 | Osteosarcoma; Macular Degeneration; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Glioma; Peritoneal Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms; Ovarian Neoplasms; Breast Neoplasms; Sarcoma; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Hemangiosarcoma; Carcinoma, Renal Cell; Solid tumours; Chondrosarcoma; Telangiectasia, Hereditary Hemorrhagic | Details |
Ripretinib | DCC-2618 | Approved | Deciphera | Qinlock, 擎乐 | United Kingdom | Gastrointestinal Stromal Tumors | Deciphera Pharmaceuticals Llc | 2020-05-15 | Mastocytosis, Systemic; Gastrointestinal Stromal Tumors | Details |
Ponatinib Hydrochloride | AP-24534; INCB-84344; AP24534 HCl; AP24534-HCL; AP24534 hydrochloride | Approved | Ariad | Iclusig | Japan | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Otsuka Holdings Co Ltd | 2012-12-14 | Leukemia; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Solid tumours; Hematologic Neoplasms; Blast Crisis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Philadelphia Chromosome; Leukemia, Myeloid, Chronic-Phase; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute; Lymphoma; Leukemia, Biphenotypic, Acute | Details |
Regorafenib | DAST; BAY-73-4506 | Approved | Bayer Ag | Resihance, Stivarga | Mainland China | Gastrointestinal Stromal Tumors | Bayer Pharma Ag | 2012-09-27 | Solid tumours; Carcinoma, Renal Cell; Rectal Neoplasms; Colonic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms | Details |
Lenvatinib Mesylate | MK-7902; ER-203492-00; E-7080 | Approved | Eisai Co Ltd | Kisplyx, Lenvima, Lenvima/Kisplyx, 乐卫玛 | Japan | Endometrial Neoplasms | Eisai Co Ltd | 2015-02-13 | Liver Diseases; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Lymphoma; Thyroid Neoplasms; Endometrial Neoplasms; Hepatic Insufficiency; Sarcoma; Urinary Bladder Neoplasms; Solid tumours; Adenocarcinoma of Lung; Thyroid Carcinoma, Anaplastic; Kidney Diseases; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Renal Insufficiency; Carcinoma, Renal Cell; Liver Neoplasms; Biliary Tract Neoplasms | Details |
Olverembatinib | D-824; GZD-824; APG-1351; GIBH-824; HQP-1351 | Approved | Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences | 耐立克 | Mainland China | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase | Guangzhou Shunjian Biomedical Technology Co Ltd | 2021-11-25 | Solid tumours; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors | Details |
Anlotinib Dihydrochloride | AL-3818 | Approved | Advenchen Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 福可维 | Mainland China | Small Cell Lung Carcinoma | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 2018-05-08 | Endometrial Neoplasms; Cholangiocarcinoma; Nasopharyngeal Carcinoma; Urologic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Bone Neoplasms; Sarcoma, Alveolar Soft Part; Gallbladder Neoplasms; Medullary thyroid cancer (MTC); Thyroid Neoplasms; Esophageal Squamous Cell Carcinoma; Lung Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Osteoma; Carcinoma, Renal Cell; Head and Neck Neoplasms; Solid tumours; Biliary Tract Neoplasms; Ovarian Neoplasms; Thoracic Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Genital Diseases, Female; Leiomyosarcoma; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma; Lymphoma, Large B-Cell, Diffuse; Sarcoma, Synovial; Neuroendocrine Tumors; Sarcoma; Bile Duct Diseases | Details |
Sorafenib Tosylate | NSC-724772; BAY-43-0006; BAY-43-9006; BAY-54-9085 | Approved | Onyx Pharmaceuticals Inc | 多吉美, Nexavar | EU | Thyroid Neoplasms | Bayer Ag | 2005-12-01 | Breast Neoplasms; Neoplasm Metastasis; Fasting; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Thyroid Neoplasms; Hepatitis C; Hepatitis B; Liver Neoplasms; Liver Diseases; Pancreatic Neoplasms; Kidney Diseases; Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms; Solid tumours; Ovarian Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Details |
Dasatinib Hydrate | BMS-354825; NSC-732517 | Approved | Bristol-Myers Squibb Company | 施达赛, Spricel, Sprycel, Spraysel | Mainland China | Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-Myers Squibb Pharma Eeig | 2006-06-28 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid; Leukemia, Lymphoid; Myelodysplastic Syndromes; Scleroderma, Systemic; Blast Crisis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Breast Neoplasms; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Acute; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung | Details |
Sunitinib Malate | PHA-290940; SU-010398; SU-11248; GB-102; PNU-290940; SU-011248-L-malate salt; PNU-290940AD; PHA-290940AD | Approved | Pfizer Pharmaceuticals Ltd (China) | Sutent, 索坦 | Japan | Pancreatic neuroendocrine tumors (pNET) | Pfizer Inc | 2006-01-26 | Breast Neoplasms; Retinal Vein Occlusion; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Carcinoma, Hepatocellular; Urogenital Neoplasms; Urologic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Diabetic macular oedema; Prostatic Neoplasms; Kidney Neoplasms; Neuroendocrine Tumors; Urologic Diseases; Kidney Diseases; Pancreatic Neoplasms; Pancreatic neuroendocrine tumors (pNET); Stomach Neoplasms; Carcinoma, Islet Cell; Carcinoma, Renal Cell; Liver Neoplasms; Solid tumours | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Telatinib | EOC-315; BAY-57-9352 | Phase 2 Clinical | Bayer Ag | Solid tumours; Stomach Neoplasms | Details |
Hydroxychloroquine/Sorafenib | Phase 1 Clinical | Vg Life Sciences | Ovarian Neoplasms | Details | |
QBH-196 | QBH-196 | Phase 1 Clinical | Shenyang Pharmaceutical University | Solid tumours; Stomach Neoplasms | Details |
Tafetinib Malate | SIM-0702; SIM-1005; SIM-010603 | Phase 1 Clinical | Jiangsu Xiansheng Pharmaceutical Co Ltd, Nanjing Yoko Biomedical Co Ltd, Jilin Boda Pharmaceutical Co Ltd | Solid tumours; Neoplasms | Details |
GS-0174 | GS-0174 | Phase 1 Clinical | Forty Seven | Hematologic Neoplasms | Details |
Imatinib mesylate (YD Global Life Science) | YD-312 | Phase 2 Clinical | Yd Global Life Science | Diabetic macular oedema | Details |
NMS-03592088 | NMS-P088; NMS-03592088 | Phase 2 Clinical | Nerviano Medical Sciences | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute | Details |
JSP-191 | AMG-191; JSP-191 | Phase 2 Clinical | Amgen Inc | Myelodysplastic Syndromes; Severe Combined Immunodeficiency; Leukemia, Myeloid, Acute; Inflammation | Details |
Imatinib dry powder inhalation (Aerovate Therapeutics) | AV-101 - Aerovate Therapeutics | Phase 3 Clinical | Pulmonary Arterial Hypertension | Details | |
Barzolvolimab | CDX-0159 | Phase 1 Clinical | Yale University, University Of Toronto - St. George Campus | Chronic Urticaria; Skin Diseases; Urticaria; Prurigo | Details |
T-1301 | T-1301; DBPR-216 | Phase 1 Clinical | Taivex Therapeutics Corp | Solid tumours; Lymphoma | Details |
THE-630 | THE-630 | Phase 2 Clinical | Theseus Pharmaceuticals Inc | Gastrointestinal Diseases; Neoplasms, Connective and Soft Tissue; Digestive System Neoplasms; Gastrointestinal Stromal Tumors; Neoplasms, Connective Tissue; Gastrointestinal Neoplasms | Details |
PLX-9486 | PLX-9486 | Phase 3 Clinical | Daiichi Sankyo Co Ltd | Hematologic Neoplasms; Mastocytosis, Systemic; Leukemia, Mast-Cell; Gastrointestinal Stromal Tumors; Mastocytosis; Neoplasm Metastasis | Details |
MGTA-117 | MGTA-117 | Phase 2 Clinical | Heidelberg, Magenta Therapeutics Inc | Myelodysplastic Syndromes; Metabolic Diseases; Leukemia, Myeloid, Acute; Anemia, Sickle Cell | Details |
Masitinib mesylate | AB-1010; AB19001 | Phase 3 Clinical | Ab Science | Prostatic Neoplasms; Melanoma; Mastocytosis; Amyotrophic Lateral Sclerosis; Alzheimer Disease; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Asthma; Psoriasis; Ovarian Neoplasms; Multiple Sclerosis; Multiple Myeloma; Multiple Sclerosis, Chronic Progressive; Coronavirus Disease 2019 (COVID-19); Mastocytosis, Systemic; Arthritis, Rheumatoid; Pancreatic Neoplasms | Details |
MG-D-1609 | MG-D-1609 | Phase 2 Clinical | Metagone Biotech | Solid tumours | Details |
Sorafenib/MG-005 | MGD-1509; MG-D-1509 | Phase 1 Clinical | Metagone Biotech, Tri-Service General Hospital | Solid tumours | Details |
This web search service is supported by Google Inc.